Reducing mortality from 2019-nCoV: host-directed therapies should be an option

Journal article

Open access

Peer reviewed

Alimuddin Zumla, David S. Hui, Esam I. Azhar, Ziad A. Memish and Markus Maeurer

The Lancet (British edition), Vol.395(10224), pp.E35-E36

22/02/2020

PMCID: PMC7133595

PMID: 32035018

Abstract

General & Internal Medicine

Life Sciences & Biomedicine

Medicine, General & Internal

Science & Technology

url

https://doi.org/10.1016/S0140-6736(20)30305-6View

Published (Version of record) Open

6 Record Views

Title: Reducing mortality from 2019-nCoV: host-directed therapies should be an option
Creators - without role: Alimuddin Zumla - University College London
David S. Hui - Chinese University of Hong Kong
Esam I. Azhar - King Abdulaziz University
Ziad A. Memish - Prince Mohammed bin Abdulaziz Hospital
Markus Maeurer - Champalimaud Foundation
Publication Details: The Lancet (British edition), Vol.395(10224), pp.E35-E36
Publisher: Elsevier
Number of pages: 2
Grant note: European & Developing Countries Clinical Trials Partnership EU's Framework Programme for Research and Innovation Bill & Melinda Gates Foundation - Champalimaud Foundation National Institutes of Health Research; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
Identifiers: 9913848808331
Academic Unit: Alfaisal University; King Abdulaziz University
Language: English
Resource Type: Journal article